Tranexamic Acid effective treatment for hemorrhagic stroke if administered early

LOS ANGELES-- Tranexamic acid can prevent death due to bleeding after trauma and post-partum haemorrhage. The researchers aimed to assess whether tranexamic acid reduces haematoma expansion and improves outcome in adults with stroke due to intracerebral haemorrhage.

They conducted a randomized trial STOP-AUST and found that Tranexamic Acid could be a treatment for hemorrhagic stroke, particularly if administered quickly.The findings of research has been presented at the American Stroke Association's International Stroke Conference 2020.

The Spot Sign and Tranexamic Acid on Preventing ICH Growth - Australasia Trial (STOP-AUST) was a multicenter, prospective, randomized, double-blind, placebo-controlled, phase 2 clinical trial using the antifibrinolytic agent tranexamic acid in people with intracerebral hemorrhage (ICH). ICH is a severe form of acute stroke with few treatment options.

Tranexamic acid is currently used to treat or prevent excessive blood loss from trauma, surgery, tooth removal, nosebleeds and heavy menstruation. For this study, one hundred patients with active brain bleeding were given either intravenous tranexamic acid or placebo within 4.5 hours of symptom onset. Researchers analyzed brain CT scans taken during the 24-hour period after treatment with tranexamic acid or placebo.